Currently out of the existing stock ratings of Suji Jeong, 16 are a BUY (80%), 4 are a HOLD (20%).

Suji Jeong

Work Performance Price Targets & Ratings Chart

Analyst Suji Jeong, carries an average stock price target met ratio of 33.33% that have a potential upside of 17.45% achieved within 261 days. Previously, Suji Jeong worked at JEFFERIES.

Suji Jeong’s has documented 38 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on VRNA, Verona Pharma PLC ADR at 09-Jul-2025.

Wall Street Analyst Suji Jeong

Analyst best performing recommendations are on INZY (INOZYME PHARMA ).
The best stock recommendation documented was for INZY (INOZYME PHARMA ) at 3/23/2023. The price target of $6 was fulfilled within 26 days with a profit of $2.7 (81.82%) receiving and performance score of 31.47.

Average potential price target upside

BLU BELLUS Health INZY Inozyme Pharma  PNT POINT Biopharma Global SVRA Savara VRNA Verona Pharma PLC ADR PRTK Paratek Pharmaceuticals ANNX Annexon  FUSN Fusion Pharmaceuticals  QURE Uniqure NV STOK Stoke Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 15-May-2023

$14.75

$0.01 (0.07%)

$14.75

Buy Since 30-Sep-2019

$14.75

$0.01 (0.07%)

Buy Since 13-Dec-2021

$14.75

$0.01 (0.07%)

$15

Buy Since 26-Jun-2020

$20

$5.26 (35.69%)

$20

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Suji Jeong?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?